COVID-19 Resources for the Specialty Chemical Industry SOCMA is proactively monitoring the COVID-19 pandemic and working with SOCMA members and... View Article
Updated April 3, 2020 Mandated closures to nonessential businesses and shelter-in-place orders have begun to proliferate in multiple state and... View Article
As specialty and fine chemical manufacturers continue to stand on the frontlines, providing valuable and life-sustaining products during this unprecedented time, the Society of Chemical Manufacturers and Affiliates (SOCMA) is providing valuable intelligence and resources to help its members and industry navigate the challenges of the COVID-19 pandemic.
The Society of Chemical Manufacturers & Affiliates (SOCMA) supports federal agency plans to grant temporary enforcement discretion during the COVID-19 pandemic.
The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.
The following guidance addresses OSHA health and safety regulatory requirements related to the current COVID-19 pandemic.
The Society of Chemical Manufacturers and Affiliates (SOCMA) today sent a letter to the White House and state governors reinforcing that specialty chemical manufacturers play a critical role in providing essential products to fight the COVID-19 pandemic.
The U.S. Environmental Protection Agency has finalized its procedural rule for the review of TSCA CBI claims. This guidance document outlines and addresses the substantiation requirements for manufacturers and processors who seek to maintain CBI claims for specific chemical identities listed on the confidential portion of the TSCA Inventory.